Navotas City unveiled on 14 January its new molecular laboratory that will provide free human papilloma virus (HPV) screening for women. HPV is the leading cause of cervical cancer and early detection will help timely treatment of the disease.

“Cervical cancer is preventable and treatable, yet many women still struggle to access proper screening and timely care,” Dr. Manuel Mapue II, development officer V of the Department of Health Metro Manila Center for Health Development, said during the launching ceremony in Barangay NBBS, Dagat-Dagatan district. “Through citywide HPV DNA testing, Navotas provides women with earlier diagnosis and ensures access to treatment and support, especially in areas beyond the reach of pap smear and VIA screening.” 

Mayor John Rey Tiangco said the program represents the city’s promise of ensuring that no Navoteña should lose her life to a preventable disease.

Roche Diagnostics Philippines (RDP) supports the program.

“Roche is proud to stand beside Navotas in advancing the WHO (World Health Organization) 90-70-90 goals to eliminate cervical cancer into local action. With our cobas® 5800 system, the city now has world-class HPV screening technology, bringing leading standards of care directly to the community,” said Marco Valencia Sanchez, RDP country manager.